RANDALL THEODORE PETERSON portrait
  • L. S. Skaggs Presidential Endowed Chair and Dean, College Of Pharmacy
  • Professor, Pharmacology And Toxicology
801-587-3064

Education

  • B.S., Molecular Biology, Brigham Young University
  • Ph.D., Biochemistry, Harvard University
  • Postdoctoral Training, Research Fellow in Medicine, Cardiovascular Research Center, Massachusetts General Hospital
  • Postdoctoral Training, Research Fellow in Medicine, Harvard Medical School

Professional Experience

Academic Appointments:    

Harvard Medical School

10/02-12/02 Instructor
01/03-06/10 Assistant Professor of Medicine  
07/10-12/16 Associate Professor of Medicine
04/14-12/16 Associate Professor of Systems Biology
04/14-12/16 Charles Addison and Elizabeth Ann Sanders Associate Professor of Basic Science

Broad Institute

08/06-09/10 Associate Member
10/10-12/16 Senior Associate Member

Massachusetts General Hospital

10/02-11/09 Assistant in Biology, Internal Medicine
11/09-09/13 Assistant Biologist, Internal Medicine
09/13-12/16 Associate Biologist, Internal Medicine
01/06-12/16 Director, Chemical Biology Program, Cardiovascular Research Center
11/09-12/16 Scientific Director, Cardiovascular Research Center 

University of Utah

01/17-Present L. S. Skaggs Presidential Endowed Chair
01/17-Present Professor, Pharmacology and Toxicology
01/17-Present Adjunct Professor, Biochemistry
01/17-Present Dean, College of Pharmacy

Other Professional Positions: 

2003-2006 Founding Scientific Advisory Board Montigen Pharmaceuticals (now Astex Pharmaceuticals)
2007 Scientific Advisory Board SuperArray Bioscience Corporation
2011-2018 Founding Scientific Advisory Board Tolero Pharmaceuticals (now Sumitomo Dainippon)
2011-2012 Scientific Advisory Board Entera Pharmaceuticals
2011-2015 Chair, Scientific Advisory Board Zephase Therapeutics
2013-2019 Founder, Scientific Advisor Teleos Therapeutics
2015 Founder Keros Therapeutics (NASDAQ: KROS)
2017-Present Board JSK Therapeutics
2018 Scientific Advisory Board Bright BioScience

Other Major Administrative Leadership Positions:

09/12-12/18 Co-Principal Investigator, NIH Center of Excellence, A discovery and development pipeline for cyanide countermeasures.
09/19-Present Co-Principal Investigator, NIH Center of Excellence, Advancing novel cyanide countermeasures.